ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI)

Overview of attention for article published in Perspectives in Drug Discovery and Design, February 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

blogs: 1 blog

wikipedia: 14 Wikipedia pages

Citations

dimensions_citation: 142 Dimensions

Readers on

mendeley: 115 Mendeley
citeulike: 5 CiteULike

Summary Blogs Wikipedia Dimensions citations

So far, Altmetric has seen 1 blog post.

Artemether: Entity of the Month

O'Really?, 05 Nov 2009

November’s entity of the month at ChEBI is the antimalarial drug Artemether. This accompanies release 62 of ChEBI, not just yet…